Mostra filtri
Tipo di risorse
Filtra per Tipo di risorse
Patologie
Filtra per Patologie
Tecnologie
Filtra per Tecnologie
Strumenti
Filtra per Strumenti
64 Risultato/i trovato/i
Ordina per:

Hemoglobinopathy Investigation – The Case for Capillary Electrophoresis

Webinar
Mar. 07, 2023

Educational Webinar with Jason EYRE

The importance of SPE and A1AT phenotyping for a better AATD patient management

Webinar
Feb. 23, 2023

Educational Webinar Pr Simone Scarlata

Modern Approach to Screening for Monoclonal Gammopathies Using Digital Workflows

Webinar
Feb. 23, 2023

Educational Webinar with Dr. Mark Zaydman from Washington University School of Medicine in St. Louis, MO

Risolvere l’interferenza sierologica da anticorpi monoclonali nei test d’immunofissazione

Webinar
Nov. 02, 2022

Sebia Academy Webinar con :

Dott.ssa Patrizia Natali,

Responsabile Settore Proteine

Sebia presenta Alegria® 2 “Any assay, any time!”

Webinar
Ott. 27, 2022

Workshop Online with :

Dott.ssa Giuseppina Barberio, già Responsabile Settore Autoimmunità, Ospedale Ca’ Foncello di Treviso

Dott. Francesco Spadarella, Product Manager, Sebia Italia

Clinical and Operational Aspects of Measuring Hemoglobin A1c by Capillary Electrophoresis

Webinar
Ott. 18, 2022

Educational Webinar with David G. Grenache, PhD, D(ABCC)
Chief Scientific Officer, TriCore Reference Laboratories

Multiple Myeloma: « 20 » and « 100 » Ratios Cut-off applicable to Sebia FLC assays

Pubblicazione
Ott. 14, 2022

The « 20 » and « 100 » Ratios Cut-off can be used in routine with Sebia FLC assays for high-risk smoldering multiple myeloma stratification and for assessing progression to active multiple myeloma or amyloidosis.

Sebia acquires Zeus Scientific

Comunicato stampa
Ott. 12, 2022

The strategic acquisition reinforces Sebia’s product portfolio & strategy in autoimmunity